Astrazeneca Pharmaceuticals Ab Sweden
- All
- News
-
Astrazeneca Pharma India Falls; SEBI Says Exchanges to Monitor Delisting
The regulator also said it came across certain reports that the offer for sale (OFS) of the shares of Astrazeneca Pharma India Ltd carried out by its promoter AstraZeneca Pharmaceuticals AB Sweden on May 26, 2013 was a deliberate attempt to subsequently get the shares of the Indian unit delisted at ease.
-
AstraZeneca surges 7.5% as board okays delisting
Shares in AstraZeneca Pharma India surged as much as 7.6 per cent on Tuesday after the company says its board approved a proposal from promoter AstraZeneca Pharmaceuticals AB, Sweden to delist the company from India.
-
Astrazeneca Pharma India soars 20% on delisting proposal
AstraZeneca Pharma India said in the filing before markets opened on Monday that its board received a request from its promoter, AstraZeneca Pharmaceuticals AB (AZP AB) Sweden, to initiate a voluntary delisting process.
-
AstraZeneca Pharma promoter to sell stake in Indian arm
AstraZeneca Pharma India said on Friday that its promoter AstraZeneca Pharmaceuticals AB Sweden plans to offload around 37 lakh shares through offer for sale route on May 28 to meet the Securities and Exchange Board of India (Sebi) norms on minimum public shareholding.
-
Astrazeneca Pharma India Falls; SEBI Says Exchanges to Monitor Delisting
The regulator also said it came across certain reports that the offer for sale (OFS) of the shares of Astrazeneca Pharma India Ltd carried out by its promoter AstraZeneca Pharmaceuticals AB Sweden on May 26, 2013 was a deliberate attempt to subsequently get the shares of the Indian unit delisted at ease.
-
AstraZeneca surges 7.5% as board okays delisting
Shares in AstraZeneca Pharma India surged as much as 7.6 per cent on Tuesday after the company says its board approved a proposal from promoter AstraZeneca Pharmaceuticals AB, Sweden to delist the company from India.
-
Astrazeneca Pharma India soars 20% on delisting proposal
AstraZeneca Pharma India said in the filing before markets opened on Monday that its board received a request from its promoter, AstraZeneca Pharmaceuticals AB (AZP AB) Sweden, to initiate a voluntary delisting process.
-
AstraZeneca Pharma promoter to sell stake in Indian arm
AstraZeneca Pharma India said on Friday that its promoter AstraZeneca Pharmaceuticals AB Sweden plans to offload around 37 lakh shares through offer for sale route on May 28 to meet the Securities and Exchange Board of India (Sebi) norms on minimum public shareholding.
